| Website | albireopharma.com |
| Category | BioTech |
| Phone | +46 31 741 14 80 |
| Employees | |
| Description | Biopharmaceutical |
| TOTAL | $40M |
| FUNDING TOTAL | $40M |
| Series A, 2/08 TPG Growth TVM Capital | $40M |
Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal (GI) area. The team has a broad experience in drug development, primarily in the GI area and has an extensive network in the international scientific and clinical communities.
